Candin Market Report 2026

Candin Market Overview

• The Candin market growth in the historic period has been driven by need for immune competency assessment, reliance on dth testing methods • Market expansion is supported by rising immunodeficiency prevalence, expansion of immune monitoring protocols • Growth Driver: Impact Of Rising Tuberculosis Cases On The Candin Market Growth • Market Trend: Leveraging Strategic Partnerships For Effective Verruca Vulgaris Treatment In The Candin Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Candin Market?

Candin is a purified extract derived from the Candida albicans organism, commonly used as a diagnostic skin test antigen to evaluate cell-mediated immunity. It functions by eliciting a delayed-type hypersensitivity (DTH) response in individuals with intact immune systems, making it valuable for assessing immune competency. Candin is typically used in healthcare settings to identify conditions such as anergy in patients suspected of having immunosuppressive disorders. The main indications for candin include candidiasis and thrush. Candidiasis is a fungal infection caused by the overgrowth of Candida species, commonly affecting areas such as the mouth, throat, skin, and genital region. It is distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies and are used by several end users such as hospitals, clinics, ambulatory care, and home care.

What Is The Candin Market Growth Forecast?

The growth in the forecast period can be attributed to rising immunodeficiency prevalence, expansion of immune monitoring protocols, growth in diagnostic testing volumes, improved clinical awareness, healthcare infrastructure development. Major trends in the forecast period include growing use of immune function diagnostic tests, expansion of cell mediated immunity assessment, rising demand for diagnostic skin testing, increased focus on immunosuppressive disorder detection, strengthening of hospital based diagnostic services.

What Are The Drivers Of The Candin Market?

The increasing prevalence of tuberculosis is expected to propel the growth of the candin market going forward. Tuberculosis (TB) is a contagious infectious disease caused by the bacterium Mycobacterium tuberculosis, primarily affecting the lungs but capable of spreading to other parts of the body, and is transmitted through airborne droplets from an infected person. Tuberculosis cases are rising due to factors such as increased transmission from untreated or undiagnosed cases, drug-resistant TB strains, gaps in healthcare access, population displacement, and the impact of co-infections like HIV, which weaken immunity. Candin helps tuberculosis by serving as a control in skin testing to evaluate cell-mediated immunity, distinguishing between immune responses caused by Mycobacterium tuberculosis and nonspecific anergic reactions in individuals with suspected tuberculosis or compromised immune function. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based national public health organization, the United States reported 9,633 tuberculosis cases in 2023, marking a 15.6% rise from the 8,332 cases recorded in 2022. Therefore, the increasing prevalence of tuberculosis is driving the growth of the candin industry. The increasing demand for personalized medicine is anticipated to drive the expansion of the candin market in the future. Personalized medicine refers to a medical approach that tailors treatment and healthcare practices based on individual patient characteristics, such as genetics, lifestyle, and environment. The rise of personalized medicine is being fueled by advancements in genomics, AI, and biotechnology, allowing for more targeted and effective treatments tailored to an individual's genetic makeup, while the growing adoption of precision diagnostics and therapies continues to expand its reach across various medical fields. Candin helps personalized medicine by offering diagnostic tools that enable healthcare providers to tailor treatments based on individual patient profiles, such as genetic factors and immune responses, thereby enhancing treatment efficacy and minimizing adverse effects, which aligns with the growing trend of precision medicine that relies on targeted therapies and personalized care strategies. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the candin industry.

Key Players In The Global Candin Market

Major companies operating in the candin market are Nielsen BioSciences Inc.

Global Candin Market Trends and Insights

The key trend in the candin market is focusing on developing strategic partnerships to offer non-invasive, cost-effective, and effective treatment options. Strategic partnerships refer to collaborative agreements between two or more organizations to leverage each other's strengths, resources, or expertise to achieve mutual goals, often involving shared risks, rewards, and responsibilities in areas such as product development, market expansion, or innovation. For instance, in May 2023, Nielsen BioSciences Inc., a US-based pharmaceutical company, announced that it has entered into a licensing agreement with Maruho Co. Ltd., a Japan-based pharmaceutical company, to sell candin in Japan as a remedy for verruca vulgaris. As a result of their partnership, Maruho will make a significant upfront payment to Nielsen and take on all costs related to the further development and regulatory activities for Candin, a diagnostic skin test aimed at treating verruca vulgaris (common warts).

What Defines the Candin Market?

The candin market consists of sales of diagnostic skin test antigens, immunotherapy products, vaccines, serology kits and recombinant antigens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Candin Market Report 2026?

The candin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the candin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.